New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
16:24 EDTORCL, SWHC, RGR, ARB, NLSN, HEB, GTATOn The Fly: Closing Wrap
Stocks on Wall Street were higher, with the buying spurred on by optimism surrounding the fiscal cliff negotiations. After surging higher during the first half of the trading session, the averages moved in a narrow range through the afternoon, though held onto gains and closed right near their highs... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: After the bell, Oracle (ORCL) reported earnings and revenues that beat Street expectations. Shares, which had been up 1.67% during the trading session, moved up another 1.5% in after hours trading following the report... Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as private equity firm Cerberus Capital Management's decision to put gunmaker Freedom Group up for sale added new pressure on those stocks. Shares of Smith & Wesson lost 86c, or 9.99%, to close at $7.79, while shares of Sturm, Ruger fell $3.40, or 7.73%, to close at $40.60... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up $8.99, or 23.63%, to $47.03 after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also gained $1.30, or 4.39%, to $30.92. Among the noteworthy losers was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw shares fall 39c, or 11.27%, to $3.07 after issuing guidance well below consensus. Also lower was Hemispherex Biopharma (HEB), down 27.6c, or 42.86%, to 36.8c, after the FDA posted documents in advance of a review of the company's Ampligen drug, noting that the agency had concerns with the drug's efficacy and safety data... INDICES: The Dow was up 115.57, or 0.87%, to 13,350.96; the Nasdaq was up 43.93, or 1.46%, to 3,054.53; and the S&P 500 was up 16.43, or 1.15%, to 1,446.79.
News For ORCL;SWHC;RGR;ARB;NLSN;HEB;GTAT From The Last 14 Days
Check below for free stories on ORCL;SWHC;RGR;ARB;NLSN;HEB;GTAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
September 10, 2014
10:00 EDTGTATOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:22 EDTGTATOn The Fly: Pre-market Movers
HIGHER: Twitter (TWTR), up 2.8% after upgraded at UBS... SunEdison (SUNE), up 2.7% after Google (GOOG) to provide $145M investment in the company's Regulus solar plant... Camtek (CAMT), up 15% after receiving new orders of $3.0M from large OSAT... Doral Financial (DRL), up 12.5% after announcing sale of approximately $430M in assets... Imperva (IMPV), up 1.5% after upgraded at Oppenheimer... Mandalay Digital (MNDL), up 13.7% after updating its guidance. UP AFTER EARNINGS: Land's End (LE), up 8.7%... Palo Alto (PANW), up 4.4%. LOWER: eBay (eBAY), down 2.6% after downgraded at Piper Jaffray following yesterday's launch of Apple Pay (AAPL)... Mobileye (MBLY), down 2.5% after downgraded at Deutsche Bank... Krispy Kreme (KKD), down 2% after Q2 earnings report... GT Advanced (GTAT), down 7% after downgraded at Goldman and Piper Jaffray... Boyd Gaming (BYD), down 3.3% after downgraded at Morgan Stanley... Urban Outfitters (URBN), down 2% after reporting Q3 SSS were so far in the low single-digits negative... Armada Hoffler (AHH), down 6% after filing to sell 5M shares of common stock... AvalonBay (AVB), down 1.8% after to sell 4.5M shares in a forward sales agreement with Goldman... AngloGold (AU), down 12% after announcing plans to restructure its international mining under a new company and saying equity capital raising being contemplated.
08:37 EDTGTATGT Advanced sapphire still a growth area longer term, says Cowen
Cowen lowered its estimates on GT Advanced (GTAT) and trimmed its price target on the stock to $18 from $19 following Apple's (AAPL) event, but the firm still believes sapphire is a growth area longer-term. Cowen sees the longer term opportunity for sapphire in improving trends in solar and the commercialization of new products.
08:35 EDTHEBHemispherx expands Ebola collaborative research agreement with governments
Hemispherx Biopharma announced that it expanded its Collaborative Research Agreement to test Alferon, the only multi-species, natural alpha interferon, or IFN, commercially approved in the U.S. and Ampligen®, an experimental drug, to be evaluated against the deadly Ebola virus also under the DEA, or Data Exchange Agreement, Annex for Medical Preparedness and Bio-Defense Agreement between the Swiss Surgeon General and the US Department of Defense. The World Health Organization has warned that "The Ebola outbreak will affect more than 20,000 people in West Africa and might spread to more countries, indicating a clinical emergency all over the world."
07:23 EDTORCLOracle coverage assumed with a Neutral at MKM Partners
Subscribe for More Information
06:21 EDTGTATGT Advanced downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
05:31 EDTGTATGT Advanced downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded GT Advanced Technologies (GTAT) to Neutral after Apple (AAPL) did not include sapphire display technology in either of the new iPhone 6 models. Goldman believes GT Advanced is the supplier of the sapphire display for Apple's new smartwatch, but views being out of the new iPhones as disappointed. The firm dropped its price target for shares to $14 from $20.
September 9, 2014
16:23 EDTGTATOn The Fly: Closing Wrap
Subscribe for More Information
15:41 EDTGTATGT Advanced down sharply on Apple iPhone rollout
Subscribe for More Information
14:00 EDTGTATGT Advanced off lows as Apple confirms sapphire glass for watch
Subscribe for More Information
13:12 EDTGTATGT Advanced drops 12% during Apple event
Subscribe for More Information
10:47 EDTGTATLeak points to no NFC or sapphire cover for smaller iPhone 6, BGR says
Subscribe for More Information
08:56 EDTGTATGT Advanced September volatility elevated into Apple event
Subscribe for More Information
07:17 EDTORCLThe Wireless Association to hold a conference
Subscribe for More Information
September 8, 2014
11:05 EDTGTATOptions with increasing implied volatility
Options with increasing implied volatility: NPSP GILD VNET AVNR GTAT YHOO RHT VRTX SDRL COV MYL
09:56 EDTGTATGT Advanced risk profile 'neutral at best' into Apple event, says Canaccord
Subscribe for More Information
08:43 EDTHEBHemispherx, USAMRIID to collaborate in studying Alferon, Ampligen
Hemispherx Biopharma announced that the company and United States Army Medical Research Institute of Infectious Diseases, or USAMRIID, scientists have agreed to test Alferon, the only multi-species, natural alpha interferon, or IFN, commercially approved in the U.S. and Ampligen, an experimental drug, to be evaluated against the deadly Ebola virus, which has been and remains a major focus of efforts at USAMRIID, a unit of the Department of Defense responsible for medical biological defense research. A key component of innate immune responses is activation of the Toll-like receptors, or TLRs. TLR3 activation by dsRNA is an essential response element to viral infection. Block TLR3 activation and an essential element of the innate immune response is disarmed. Ampligen, Poly I:Poly C12U was designed as an IFN inducer and has demonstrated antiviral activity in a wide variety of DNA and RNA viruses in pre-clinical testing. Replenishing an Ebola patient's natural interferon with Alferon and restoring that patient's innate immune response by Ampligen's overcoming the Ebola blocking mechanisms could potentially reduce the morbidity and mortality of Ebola virus disease.
07:22 EDTGTATFormer GT Advanced manager points to sapphire covers at Apple, MacRumors says
While neither Apple (AAPL) nor GT Advanced (GTAT) have confirmed that Apple plans to use sapphire covers for its upcoming iPhones, a former product manager at GT claims on his LinkedIn profile that he played a key role in selling Apple on sapphire display covers for its "mobile devices," according to MacRumors, citing a prior report from TechViking. Reference Link
06:24 EDTGTATGT Advanced September volatility elevated into Apple event
Subscribe for More Information
06:02 EDTGTATStocks with implied volatility above IV index mean; PLUG GATE
Stocks with implied volatility top IV index mean; Plug Power (PLUG) 79, GT Advanced (GTAT) 91 according to iVolatility.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use